Sino Biological Stock Hits Day Low of CNY 65.66 Amid Price Pressure

Sino Biological Inc., a mid-cap player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline today, with its stock price dropping by 5.71%. The stock reached an intraday low of CNY 65.66, reflecting broader market trends as the China Shanghai Composite index fell by 3.63% on the same day. Over the past week, Sino Biological has seen a decrease of 8.02%, and its performance over the last month shows a decline of 9.42%. Despite a modest annual gain of 4.04%, the company has faced significant challenges, with a three-year performance drop of 35.45%. Financial metrics indicate a concerning trend, with net sales declining at an annual rate of 16.93% and operating profit decreasing by 52.02% over the last five years. The company has reported negative results for five consecutive quarters, and its operating cash flow is at a low of CNY 199.18 million. Additionally, the inventory turnover ratio stands at 3.15 times, the lowest in the half-year period. Sino Biological's current valuation reflects a price-to-book ratio of 0.81 and a return on equity of 2.46%, alongside a dividend yield of 6.82%.